SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-014643
Filing Date
2024-02-13
Accepted
2024-02-13 17:05:14
Documents
14
Period of Report
2024-02-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20240213.htm   iXBRL 8-K 40293
2 EX-99.1 meip-ex99_1.htm EX-99.1 170594
3 GRAPHIC img183464774_0.jpg GRAPHIC 80752
  Complete submission text file 0000950170-24-014643.txt   443317

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20240213.xsd EX-101.SCH 23892
15 EXTRACTED XBRL INSTANCE DOCUMENT meip-20240213_htm.xml XML 4524
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 24628457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)